IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
Status:
Completed
Trial end date:
2017-11-11
Target enrollment:
Participant gender:
Summary
This trial is designed to determine the feasibility of conventional induction chemotherapy,
IFNand G-CSF mobilized DLI (IFN-DLI) in subjects with relapsed AML and ALL after allo-SCT.
Phase:
Early Phase 1
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania